KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) Cost of Revenue: 2009-2024

Historic Cost of Revenue for Thermo Fisher Scientific (TMO) over the last 16 years, with Dec 2024 value amounting to $12.7 billion.

  • Thermo Fisher Scientific's Cost of Revenue rose 4.70% to $3.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $12.9 billion, marking a year-over-year increase of 0.76%. This contributed to the annual value of $12.7 billion for FY2024, which is 3.90% down from last year.
  • Per Thermo Fisher Scientific's latest filing, its Cost of Revenue stood at $12.7 billion for FY2024, which was down 3.90% from $13.2 billion recorded in FY2023.
  • Over the past 5 years, Thermo Fisher Scientific's Cost of Revenue peaked at $14.2 billion during FY2022, and registered a low of $11.4 billion during FY2020.
  • Its 3-year average for Cost of Revenue is $13.4 billion, with a median of $13.2 billion in 2023.
  • As far as peak fluctuations go, Thermo Fisher Scientific's Cost of Revenue increased by 19.17% in 2021, and later fell by 7.57% in 2023.
  • Over the past 5 years, Thermo Fisher Scientific's Cost of Revenue (Yearly) stood at $11.4 billion in 2020, then grew by 19.17% to $13.6 billion in 2021, then grew by 4.80% to $14.2 billion in 2022, then decreased by 7.57% to $13.2 billion in 2023, then fell by 3.90% to $12.7 billion in 2024.